comorbidity of diabetes and hypertension
Conditions
Interventions
Rural physicians:Provide an AI agent with functions of clinical medication
Patients:Reduce potentially inappropriate medication(deprescribing)
Sponsors
The Second Affiliated Hospital, Zhejiang University School of Medicine
Eligibility
Sex/Gender
All
Age
65 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria for rural physicians:(1) A minimum of two years of clinical practice in rural primary healthcare institutions; (2) Hold a practicing physician qualification;(3) Currently managing at least 100 patients with concurrent primary hypertension and/or type 2 diabetes mellitus; (4) Demonstrated proficiency in basic computer operations and internet usage. Inclusion criteria for patients:(1) Age 65 years or older; (2) Documented diagnosis of primary hypertension and type 2 diabetes mellitus according to ICD-10 criteria; (3) Currently receiving five or more long-term medications (including both prescription and over-the-counter drugs); (4) Expected to remain in the local area throughout the study period and be available for follow-up visits.
Exclusion criteria
Exclusion criteria: Exclusion criteria for rural physicians:(1) Anticipated resignation or extended leave during the study period; (2) Concurrent enrollment in other clinical research that may confound study outcomes; (3) Refusal to provide written informed consent. Exclusion criteria for patients:(1) Presence of severe cognitive impairment or psychiatric illness precluding study participation; (2) Life expectancy less than 12 months; (3) Acute cardiovascular event or hospitalization for acute exacerbation of chronic disease within the preceding three months; (4) Refusal to provide written informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total number of medications; | — |
Secondary
| Measure | Time frame |
|---|---|
| Number of potentially inappropriate medications (PIMs) ;Medication Appropriateness Index (MAI) ;Incidence of adverse drug reactions;Blood pressure;Fasting plasma glucose;lycated haemoglobin (HbA1c);Acceptability of Intervention Measure (AIM);Intervention Appropriateness Measure (IAM);Feasibility of Intervention Measure (FIM); | — |
Countries
China
Contacts
Public ContactWu Lingyan
The Second Affiliated Hospital, Zhejiang University School of Medicine
Outcome results
None listed